2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow faricimab: new trials by email Literature Review of faricimab trials Research Report on faricimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) RO7823653, Faricimab - Diabetic Macular Edema | Phase 1 | Recruiting | Genentech, Inc. | 93 | 2026-04-21 | 2026-11-09 |
| A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 Faricimab, OLN324 - Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration | Phase 1 | Completed | Ollin Biosciences, Inc. | 164 | 2025-02-12 | 2026-03-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema RO7446603, Aflibercept, Faricimab - Diabetic Macular Edema | Phase 1 / Phase 2 | Completed | Genentech, Inc. | 388 | 2022-06-22 | 2026-06-23 |
Genentech, Inc. (2) · Ollin Biosciences, Inc. (1)
United States (3) · Puerto Rico (2) · China (1)